Literature DB >> 14627331

Nonalcoholic steatohepatitis--a long-term follow-up study: comparison with alcoholic hepatitis in ambulatory and hospitalized patients.

Helena Cortez-Pinto1, Amélia Baptista, Maria Ermelinda Camilo, Miguel Carneiro De Moura.   

Abstract

A previous publication analyzed the clinicopathological characteristics of 105 patients with steatohepatitis: 32 nonalcoholic, 21 ambulatory alcoholics, and 52 hospitalized alcoholics; we now report an up to 12-year follow-up (mean 5.9 +/- 4.7). Between 1988 and 1993, all patients with a histological diagnosis of steatohepatitis were included; necrosis, inflammation, Mallory bodies, and fibrosis were graded. Complete follow-up data were obtained in 78%. Survival curves were similar between nonalcoholic and ambulatory alcoholics; they were, however, better in nonalcoholic than hospitalized alcoholics (P < 0.0001), and in ambulatory relative to hospitalized (P = 0.0001) alcoholics. Nonalcoholics had a better prognosis than the combined alcoholic groups (P = 0.001). Patients with moderate to severe Mallory bodies and severe fibrosis had a significantly worse survival (P < 0.01), whereas severity of hepatocellular damage and neutrophil or mononuclear infiltration had no significant impact. In conclusion, alcoholic patients as a whole had a worse prognosis, yet the ambulatory subgroup had a prognosis similar to nonalcoholic patients.

Entities:  

Mesh:

Year:  2003        PMID: 14627331     DOI: 10.1023/a:1026152415917

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  Liver disease of the alcoholic.

Authors:  C M Leevy; C H Tamburro; R Zetterman
Journal:  Med Clin North Am       Date:  1975-07       Impact factor: 5.456

2.  Chemotactic activity for human PMN generated during ethanol metabolism by rat hepatocytes: role of glutathione and glutathione peroxidase.

Authors:  B A Neuschwander-Tetri; F J Roll
Journal:  Biochem Biophys Res Commun       Date:  1990-03-30       Impact factor: 3.575

3.  Long-term prognosis of patients with cirrhosis of the liver and upper gastrointestinal bleeding.

Authors:  H C Pinto; A Abrantes; A V Esteves; H Almeida; J P Correia
Journal:  Am J Gastroenterol       Date:  1989-10       Impact factor: 10.864

Review 4.  Nonalcoholic steatohepatitis.

Authors:  S G Sheth; F D Gordon; S Chopra
Journal:  Ann Intern Med       Date:  1997-01-15       Impact factor: 25.391

5.  Sequential acetaldehyde production, lipid peroxidation, and fibrogenesis in micropig model of alcohol-induced liver disease.

Authors:  O Niemelä; S Parkkila; S Ylä-Herttuala; J Villanueva; B Ruebner; C H Halsted
Journal:  Hepatology       Date:  1995-10       Impact factor: 17.425

Review 6.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

Authors:  H Esterbauer; R J Schaur; H Zollner
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

7.  Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients.

Authors:  H C Pinto; A Baptista; M E Camilo; A Valente; A Saragoça; M C de Moura
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

8.  Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage.

Authors:  A Parés; J Caballería; M Bruguera; M Torres; J Rodés
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

9.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

10.  The natural history of nonalcoholic fatty liver: a follow-up study.

Authors:  M R Teli; O F James; A D Burt; M K Bennett; C P Day
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425

View more
  18 in total

Review 1.  Non-alcoholic fatty liver disease: The diagnosis and management.

Authors:  Shehab M Abd El-Kader; Eman M Salah El-Den Ashmawy
Journal:  World J Hepatol       Date:  2015-04-28

2.  Keratin 8 phosphorylation regulates its transamidation and hepatocyte Mallory-Denk body formation.

Authors:  Raymond Kwan; Shinichiro Hanada; Masaru Harada; Pavel Strnad; Daniel H Li; M Bishr Omary
Journal:  FASEB J       Date:  2012-02-23       Impact factor: 5.191

Review 3.  The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis.

Authors:  Mangesh R Pagadala; Arthur J McCullough
Journal:  Clin Liver Dis       Date:  2012-06-27       Impact factor: 6.126

Review 4.  Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?

Authors:  Henry Völzke
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

Review 5.  Treatment of non-alcoholic fatty liver disease.

Authors:  L A Adams; P Angulo
Journal:  Postgrad Med J       Date:  2006-05       Impact factor: 2.401

6.  Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C.

Authors:  Mina O Rakoski; Morton B Brown; Robert J Fontana; Herbert L Bonkovsky; Elizabeth M Brunt; Zachary D Goodman; Anna S Lok; M Bishr Omary
Journal:  Clin Gastroenterol Hepatol       Date:  2011-07-23       Impact factor: 11.382

Review 7.  Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease.

Authors:  Shane J Mills; Stephen A Harrison
Journal:  Curr Gastroenterol Rep       Date:  2005-02

Review 8.  Pathogenesis and management issues for non-alcoholic fatty liver disease.

Authors:  Marko Duvnjak; Ivan Lerotić; Neven Barsić; Vedran Tomasić; Lucija Virović Jukić; Vedran Velagić
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

9.  The Worsening Profile of Alcoholic Hepatitis in the United States.

Authors:  Tuyet A Nguyen; Jonathan P DeShazo; Leroy R Thacker; Puneet Puri; Arun J Sanyal
Journal:  Alcohol Clin Exp Res       Date:  2016-05-05       Impact factor: 3.455

10.  CD73 (ecto-5'-nucleotidase) hepatocyte levels differ across mouse strains and contribute to mallory-denk body formation.

Authors:  Natasha T Snider; Nicholas W Griggs; Amika Singla; David S Moons; Sujith V W Weerasinghe; Anna S Lok; Chunhai Ruan; Charles F Burant; Hari S Conjeevaram; M Bishr Omary
Journal:  Hepatology       Date:  2013-08-26       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.